Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Barbui

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Epidemiology and Psychiatric Sciences|September 20, 2011
Cochrane reviews impact on mental health policy and practiceC Barbui, M Tansella
Epidemiology and Psychiatric Sciences|October 31, 2015
Comparative effectiveness of long-acting antipsychotics: issues and challenges from a pragmatic randomised studyG Ostuzzi, C Barbui
Epidemiology and Psychiatric Sciences|January 29, 2016
Discontinuing benzodiazepines: best practicesG Guaiana, C Barbui
Epidemiology and Psychiatric Sciences|September 3, 2015
From the 16th to the 21st Century: how we approach mental health problems and where do we go next?P Dazzan, C Barbui
Epidemiology and Psychiatric Sciences|December 19, 2014
Adherence to generic v. brand antidepressant treatment and the key role of health system factorsC Barbui, V Conti
Epidemiology and Psychiatric Sciences|July 17, 2012
Guideline implementation in mental health: current status and future goalsC Barbui, M Tansella
Epidemiology and Psychiatric Sciences|October 24, 2012
Dichotomizing rating scale scores in psychiatry: a bad idea?M Purgato, C Barbui
Epidemiology and Psychiatric Sciences|July 15, 2014
Antidepressant dose and the risk of deliberate self-harmC Barbui, S B Patten
Epidemiology and Psychiatric Sciences|July 14, 2018
Safety of psychotropic medicines: looking beyond randomised evidenceC Barbui, S B Patten
Acta Psychiatrica Scandinavica|March 28, 1998
A cross-sectional audit of benzodiazepine use among general practice patientsC Barbui, M Gregis, M Zappa
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Epidemiology and Psychiatric Sciences|September 20, 2011
Cochrane reviews impact on mental health policy and practiceC Barbui, M Tansella
Epidemiology and Psychiatric Sciences|October 31, 2015
Comparative effectiveness of long-acting antipsychotics: issues and challenges from a pragmatic randomised studyG Ostuzzi, C Barbui
Epidemiology and Psychiatric Sciences|January 29, 2016
Discontinuing benzodiazepines: best practicesG Guaiana, C Barbui
Epidemiology and Psychiatric Sciences|September 3, 2015
From the 16th to the 21st Century: how we approach mental health problems and where do we go next?P Dazzan, C Barbui
Epidemiology and Psychiatric Sciences|December 19, 2014
Adherence to generic v. brand antidepressant treatment and the key role of health system factorsC Barbui, V Conti
Epidemiology and Psychiatric Sciences|July 17, 2012
Guideline implementation in mental health: current status and future goalsC Barbui, M Tansella
Epidemiology and Psychiatric Sciences|October 24, 2012
Dichotomizing rating scale scores in psychiatry: a bad idea?M Purgato, C Barbui
Epidemiology and Psychiatric Sciences|July 15, 2014
Antidepressant dose and the risk of deliberate self-harmC Barbui, S B Patten
Epidemiology and Psychiatric Sciences|July 14, 2018
Safety of psychotropic medicines: looking beyond randomised evidenceC Barbui, S B Patten
Acta Psychiatrica Scandinavica|March 28, 1998
A cross-sectional audit of benzodiazepine use among general practice patientsC Barbui, M Gregis, M Zappa
Pageof 11